Teligent Approved for Triamcinolone Acetonide Ointment

The ointment is expected to launch later this year
The ointment is expected to launch later this year

Teligent announced that the Food and Drug Administration (FDA) has approved Triamcinolone Acetonide Ointment, 0.1%.

Triamcinolone Acetonide Ointment is a topical steroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids share anti-inflammatory antipruritic and vasoconstrictive properties. The exact mechanism of anti-inflammatory activity is unclear but some evidence suggests that a correlation exists between vasoconstrictor potency and therapeutic efficacy. 

Related Articles

Teligent's Triamcinolone Acetonide Ointment 1% will be available as 15g and 80g tubes and a 1lb jar. It is expected to launch in the second quarter of 2016.

For more information call (856) 697-1441 or visit